Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? (Q36188436)

12 August 2017

1 reference

title

Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? (English)

1 reference

12 August 2017

1 reference

Christos Chatziantoniou

series ordinal

1

1 reference

12 August 2017

Jean-Claude Dussaule

series ordinal

2

1 reference

12 August 2017

publication date

1 August 2005

1 reference

American Journal of Physiology - Renal Physiology

12 August 2017

published in

1 reference

12 August 2017

volume

289

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

F227-34

1 reference

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Regression of renal vascular fibrosis by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Role of aldosterone in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Bone morphogenetic proteins in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Regression of IgA nephropathy: a repeat biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Tissue transglutaminase and the progression of human renal scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Peroxisome proliferator-activated receptor-α regulates postischemic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00453.2004

10.1152/AJPRENAL.00453.2004

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference